Learn / NVO
NYSE: NVONovo Nordisk A S (NVO) stock, explained like you're 5
Novo Nordisk A S trades on the New York Stock Exchange under the ticker NVO. It is a large cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 171.1 billion dollars.
- Ticker
- NVO
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Large cap, about 171.1 billion dollars
Is Novo Nordisk A S a small, medium or large cap company?
Yes. Novo Nordisk A S is a large cap stock. Its market cap, which is the total value of all its shares, is about 171.1 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Novo Nordisk A S makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves NVO stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Novo Nordisk (NVO) Could Be 63% Undervalued Following Its Share Buyback (Yahoo Finance)
- NVO Stock Slumps After Late Stage Trial Fails Primary Goal Retail Says ‘Current Revenue Drivers’ Still Intact (Stocktwits)
- Novo Nordisk (NVO) Stock May Be Undervalued As Buybacks Continue (Simply Wall Street)
- Novo Nordisk A/S Stock (NVO) Moved Up by 3.38% on Oct 15: What Investors Need To Know (TradingKey)
- NVO Nov 2026 44.000 call (NVO261113C00044000) Stock Historical Prices & Data (Yahoo! Finance Canada)
Follow NVO in your daily brief
Each trading day at 5 PM ET we post what happened to Novo Nordisk A S and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow NVO
Questions about Novo Nordisk A S stock
What does Novo Nordisk A S do?
Novo Nordisk A S trades on the New York Stock Exchange under the ticker NVO. It is a large cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 171.1 billion dollars.
What is the ticker symbol for Novo Nordisk A S?
Novo Nordisk A S trades under the ticker NVO on the New York Stock Exchange.
What is Novo Nordisk A S's market cap?
Novo Nordisk A S is a large cap stock with a market cap of about 171.1 billion dollars.
How does Novo Nordisk A S make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves NVO stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow NVO stock every day?
Add NVO to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.
